Biotech company gets millions for the development of drug against hearing loss
The new biotech company Hoba Therapeutics, which is developing a potential pain treatment, is hoping the drug will be effective as a medical treatment for hearing loss. The company has received a grant from the Danish Innovation Fund to continue its work in this area.
BY ALBERT RØNNING-ANDERSSON, TRANSLATED BY NIELSINE NIELSEN
Log in to read our articles
Welcome to MedWatch. A part of our content is exclusive and reserved for our users.